Clinical Trial Update: Effects of Thymoglobulin on Human B Cells

View source ↗

Summary

A clinical trial studying the effects of Thymoglobulin on human B cells in acute and chronic humoral rejection contexts has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Humoral Rejection

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Northwestern University | Conditions: Acute Humoral Rejections, Chronic Humoral Rejections | Status: WITHDRAWN